QMSMEDI

QMS Medical Allied Services Limited

Healthcare solutions platform with medical distribution and patient engagement services

Healthcare›Healthcare›Healthcare Equipment & Supplies›Medical Equipment & Supplies

qmsmas.com

Ask AI

Key metrics

Price as of 2026-10-16

Stock price

₹171.06

Market cap

331 Cr

Stock P/E

35.7

P/B

3.17

Dividend yield

0.3%

ROE (FY26)

11.4%

ROCE (FY26)

22.1%

Operating margin (FY26)

12.7%

Debt / equity (FY26)

0.0012

OCF / EBITDA (FY26)

75.1%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

QMS Medical Allied Services (QMS) supplies medical and healthcare products to pharmaceutical companies, hospitals and clinics, and runs healthcare screening camps and patient support programmes (PSPs) for pharmaceutical companies.

Company snapshot

7thBy market cap

Ranked among 8 companies in Medical Equipment & Supplies.

What we see

Positives

✓Cash flow from operations is higher than reported profit — earnings quality looks solid.

1 more signal from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

Metric	Jun 2025	Sept 2025¹	Dec 2025	Jun 2026
Sales	46 Cr	45 Cr	37 Cr	57 Cr
Operating expenses (approx.)	40 Cr	38 Cr	31 Cr	49 Cr
EBITDA	6 Cr	7 Cr	7 Cr	8 Cr
OPM %	13.9%	15.5%	18.1%	14.6%
Other income	0.32 Cr	0.22 Cr	0.30 Cr	0.42 Cr
Interest	1 Cr	1 Cr	2 Cr	2 Cr
Depreciation	0.86 Cr	0.94 Cr	1 Cr	1 Cr
Profit before tax	4 Cr	5 Cr	4 Cr	6 Cr
Tax %	29.6%	—	25.8%	28.7%
Net profit	6 Cr	0.42 Cr	3 Cr	4 Cr
EPS (₹)	₹1.64	—	₹1.24	₹2.05

1Sept 2025: Derived from year-to-date: the half-year to 30 Sep 2025 less the quarter to 30 Jun 2025; the filing gives no figures for this quarter alone

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

Metric	Mar 2025	Mar 2026	TTM
Sales	156 Cr	173 Cr	Sign in free for the trailing twelve months
Operating expenses (approx.)	131 Cr	147 Cr	Sign in free for the trailing twelve months
EBITDA	25 Cr	26 Cr	Sign in free for the trailing twelve months
OPM %	16.3%	15.0%	Sign in free for the trailing twelve months
Other income	2 Cr	1 Cr	Sign in free for the trailing twelve months
Interest	5 Cr	7 Cr	Sign in free for the trailing twelve months
Depreciation	4 Cr	4 Cr	Sign in free for the trailing twelve months
Profit before tax	19 Cr	16 Cr	Sign in free for the trailing twelve months
Tax %	26.6%	27.5%	Sign in free for the trailing twelve months
Net profit	14 Cr	12 Cr	Sign in free for the trailing twelve months
EPS (₹)	₹6.77	₹5.40	Sign in free for the trailing twelve months
Dividend payout %	6.5%	7.5%	Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

Metric	Mar 2025	Mar 2026
Equity capital	18 Cr	19 Cr
Reserves	72 Cr	85 Cr
Borrowings	—	—
Other liabilities	100 Cr	109 Cr
Total liabilities	190 Cr	213 Cr
Fixed assets (net)	23 Cr	23 Cr
CWIP	—	—
Investments	3 Cr	5 Cr
Inventories	39 Cr	46 Cr
Trade receivables	43 Cr	67 Cr
Cash & bank	1 Cr	1 Cr
Other assets	80 Cr	70 Cr
Total assets	190 Cr	213 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

Metric	Mar 2025	Mar 2026
Cash from operating activity	20 Cr	19 Cr
Cash from investing	-45 Cr	-20 Cr
Cash from financing	26 Cr	1 Cr
Net cash flow	0.52 Cr	0.13 Cr
Free cash flow (OCF − Capex)	-28 Cr	14 Cr

Ratios

Metric	Mar 2025	Mar 2026
ROCE %	26.0%	22.1%
ROE %	15.3%	11.4%
Debtor days	101	142
Inventory days	92	97
Days payable	39	39
Cash conversion cycle	153	200
OCF / EBITDA %	79.2%	75.1%
Debt / equity	—	0.0012
Current ratio	1.64	1.56
Net debt / EBITDA	-0.04	-0.05